North Korea - Treatment Success Rate for Patients Treated for Multidrug-Resistant Tuberculosis
Since 2014, North Korea Treatment Success Rate for Patients Treated for Multidrug-Resistant Tuberculosis was down by 3.3points year on year. At 77 Percent in 2019, the country was ranked number 102 comparing other countries in Treatment Success Rate for Patients Treated for Multidrug-Resistant Tuberculosis. Norway topped the ranking with 108 Percent in 2019, a growth of 2.9points compared to 2018. Austria, Burundi and Marshall Islands respectively ranked number 2, 3 and 4 in this ranking. Equatorial Guinea witnessed the best average annual growth at +34.3points per year, while United Arab Emirates was the worst growing country at -100points per year.
Loading...
| Date | Percent |
|---|---|
| 2019 | 77.00 |
| 2018 | 77.00 |
| 2017 | 78.00 |
| 2016 | 80.00 |
| 2015 | 73.00 |
Download all data from 2012 to 2019
How does North Korea rank in Treatment Success Rate for Patients Treated for Multidrug-Resistant Tuberculosis?
| # | 313 Countries | Percent | Last | YoY | 5‑years CAGR | ||
|---|---|---|---|---|---|---|---|
| 1 |
#1
Norway
|
108.00 % | 2019 | +2.9 % | +3.7 % | View data | |
| 2 |
#2
Austria
|
107.00 % | 2019 | +4.9 % | +11.2 % | View data | |
| 102 |
#102
Bangladesh
|
77.00 % | 2019 | +0.0 % | +0.8 % | View data | |
| 102 |
#102
North Korea
|
77.00 % | 2019 | +0.0 % | -3.3 % | View data | |
| 102 |
#102
Sudan
|
77.00 % | 2019 | +4.0 % | +0.8 % | View data | |